Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 1.7B | 1.8B | 1.6B | 2.2B |
Cost of revenue | 388M | 846M | 387M | 600M |
Gross profit | 1.3B | 961M | 1.2B | 1.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 402M | -605M | 307M | 569M |
Operating income | 620M | 612M | 616M | 809M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 4M | 5M | 34M | 0 |
Other income expense | — | — | — | — |
Pretax income | 668M | 628M | 612M | 839M |
Tax provision | 168M | 185M | 162M | 212M |
Net income | 500M | 443M | 450M | 627M |
Basic EPS | 21.7 | — | 19.5 | 27.2 |
Diluted EPS | 21.7 | — | 19.5 | 27.2 |
Basic average shares | 23.1M | — | 23.0M | 23.0M |
Diluted average shares | 23.1M | — | 23.0M | 23.0M |
EBITDA | 692M | 672M | 673M | 848M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |